The Methyl Anthranilate market has accelerated over the past 12‑18 months, driven by strategic alliances, regulatory shifts, and innovative product launches that are reshaping flavor and fragrance applications. In early 2025, FlavorTech partnered with GreenLeaf Biosciences to co‑develop a sustainably sourced, high‑purity Methyl Anthranilate for natural‑fruit flavoring, leveraging GreenLeaf’s fermentation platform. Mid‑2025 saw Givaudan acquire boutique aroma house AromaNova, adding a proprietary micro‑encapsulation technology that boosts aroma stability in high‑temperature processes. In July 2025, Takasago introduced a low‑odor, water‑soluble Methyl Anthranilate variant designed for e‑liquids, responding to the rapid growth of nicotine‑free vaping. The European Union’s revised food‑additive directive, effective January 2026, raised the permissible daily intake, opening new opportunities in confectionery. Meanwhile, a $45 million Series B round secured by BioFlavor Labs will fund expansion of its bio‑fermentation facilities in Brazil, targeting cost‑competitive supply for emerging markets. Collectively, these moves illustrate evolving Methyl Anthranilate industry trends toward sustainability, functional delivery, and geographic diversification.